Copeland Capital Management, LLC Novo Nordisk A S Transaction History

Copeland Capital Management, LLC

  • $4.7 Billion
  • Q3 2025

A detailed history of Copeland Capital Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Copeland Capital Management, LLC holds 641 shares of NVO stock, worth $31,062. This represents 0.0% of its overall portfolio holdings.

Number of Shares
641
Previous 579 10.71%
Holding current value
$31,062
Previous $39,000 10.26%
% of portfolio
0.0%
Previous 0.0%

Shares

38 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 17, 2025
BUY
$45.38 - $71.7 $2,813 - $4,445
62 Added 10.71%
641 $35,000
Q2 2025

Jul 21, 2025
BUY
$58.08 - $81.05 $10,802 - $15,075
186 Added 47.33%
579 $39,000
Q1 2025

Apr 24, 2025
BUY
$69.3 - $90.95 $17,671 - $23,192
255 Added 184.78%
393 $27,000
Q4 2024

Jan 24, 2025
BUY
$85.0 - $120.04 $2,635 - $3,721
31 Added 28.97%
138 $11,000
Q3 2024

Oct 21, 2024
BUY
$119.07 - $145.42 $12,740 - $15,559
107 New
107 $12,000
Q1 2024

Apr 19, 2024
BUY
$102.11 - $135.92 $10,823 - $14,407
106 Added 44.73%
343 $44,000
Q4 2023

Jan 19, 2024
SELL
$87.78 - $105.45 $3,950 - $4,745
-45 Reduced 15.96%
237 $24,000
Q3 2023

Oct 23, 2023
BUY
$90.94 - $199.54 $12,822 - $28,135
141 Added 100.0%
282 $25,000
Q1 2023

Apr 14, 2023
SELL
$132.34 - $159.14 $4,234 - $5,092
-32 Reduced 18.5%
141 $22,000
Q1 2022

Apr 18, 2022
SELL
$93.1 - $112.54 $3,258 - $3,938
-35 Reduced 16.83%
173 $19,000
Q4 2021

Jan 18, 2022
SELL
$95.88 - $117.08 $4,314 - $5,268
-45 Reduced 17.79%
208 $23,000
Q3 2021

Jan 18, 2022
BUY
$84.42 - $106.62 $21,358 - $26,974
253 New
253 $24,000
Q3 2021

Oct 20, 2021
SELL
$84.42 - $106.62 $21,358 - $26,974
-253 Closed
0 $0
Q2 2021

Jan 18, 2022
BUY
$67.66 - $84.76 $17,117 - $21,444
253 New
253 $21,000
Q2 2021

Jul 19, 2021
SELL
$67.66 - $84.76 $17,117 - $21,444
-253 Closed
0 $0
Q1 2021

Jan 18, 2022
BUY
$67.06 - $75.82 $16,966 - $19,182
253 New
253 $17,000
Q1 2021

Apr 26, 2021
SELL
$67.06 - $75.82 $16,966 - $19,182
-253 Closed
0 $0
Q4 2020

Jan 18, 2022
BUY
$63.89 - $73.8 $16,164 - $18,671
253 New
253 $18,000
Q4 2020

Jan 27, 2021
SELL
$63.89 - $73.8 $74,559 - $86,124
-1,167 Closed
0 $0
Q3 2020

Jan 18, 2022
BUY
$63.69 - $70.22 $74,326 - $81,946
1,167 New
1,167 $81,000
Q3 2020

Oct 22, 2020
SELL
$63.69 - $70.22 $91,395 - $100,765
-1,435 Closed
0 $0
Q2 2020

Jan 18, 2022
BUY
$58.54 - $67.94 $84,004 - $97,493
1,435 New
1,435 $94,000
Q2 2020

Jul 30, 2020
SELL
$58.54 - $67.94 $135,520 - $157,281
-2,315 Closed
0 $0
Q1 2020

Jan 18, 2022
BUY
$49.46 - $64.78 $114,499 - $149,965
2,315 New
2,315 $139,000
Q1 2020

Apr 29, 2020
SELL
$49.46 - $64.78 $12,513 - $16,389
-253 Closed
0 $0
Q4 2019

Jan 18, 2022
BUY
$49.86 - $58.26 $12,614 - $14,739
253 New
253 $15,000
Q4 2019

Feb 03, 2020
SELL
$49.86 - $58.26 $73,792 - $86,224
-1,480 Closed
0 $0
Q3 2019

Jan 18, 2022
BUY
$47.54 - $53.43 $70,359 - $79,076
1,480 New
1,480 $77,000
Q3 2019

Nov 06, 2019
SELL
$47.54 - $53.43 $74,447 - $83,671
-1,566 Closed
0 $0
Q2 2019

Jan 18, 2022
BUY
$46.79 - $52.47 $73,273 - $82,168
1,566 New
1,566 $80,000
Q2 2019

Jul 19, 2019
SELL
$46.79 - $52.47 $57,270 - $64,223
-1,224 Closed
0 $0
Q1 2019

Jan 18, 2022
BUY
$46.36 - $52.63 $56,744 - $64,419
1,224 New
1,224 $64,000
Q1 2019

Apr 24, 2019
SELL
$46.36 - $52.63 $568,466 - $645,349
-12,262 Closed
0 $0
Q4 2018

Jan 28, 2019
BUY
$41.54 - $47.25 $111,493 - $126,819
2,684 Added 28.02%
12,262 $565,000
Q3 2018

Nov 01, 2018
SELL
$46.76 - $51.24 $2,665 - $2,920
-57 Reduced 0.59%
9,578 $452,000
Q1 2018

May 04, 2018
BUY
$48.49 - $58.14 $12,364 - $14,825
255 Added 2.72%
9,635 $475,000
Q4 2017

Jan 30, 2018
SELL
$47.53 - $53.73 $9,268 - $10,477
-195 Reduced 2.04%
9,380 $503,000
Q3 2017

Oct 27, 2017
BUY
$41.15 - $49.22 $394,011 - $471,281
9,575
9,575 $461,000

Others Institutions Holding NVO

# of Institutions
1,684
Shares Held
304M
Call Options Held
25.9M
Put Options Held
43.8M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Copeland Capital Management, LLC Portfolio

Follow Copeland Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Copeland Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copeland Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email